Ready to find the right treatment? Upload medical records & instantly get program matches.

Follicular Lymphoma — Expanded Access Programs

Overview

Right2Hope maintains a directory of 42 expanded access programs, clinical trials, and compassionate use pathways listed for Follicular Lymphoma. Each entry below was sourced from sponsor disclosures and public clinical-trial registries. Use this hub to understand the breadth of ongoing research, identify sponsors with follicular lymphoma programs, and link out to specific protocols for eligibility, contact, and request details. Of these, 41 programs are currently active or recruiting, with the remaining 1 in other lifecycle stages. Sponsors actively running programs in this area include M.D. Anderson Cancer Center, Masonic Cancer Center, University of Minnesota, Reid Merryman, MD, H. Lee Moffitt Cancer Center and Research Institute, Memorial Sloan Kettering Cancer Center, and others.

By recruiting status

Snapshot of where every Follicular Lymphoma program currently sits in its lifecycle.

  • Active / Recruiting
    41
  • Inactive
    1

Top sponsors

Organisations running the most Follicular Lymphoma programs in the directory.

Follicular Lymphoma records (42)

Clinical trials and expanded access programs registered for Follicular Lymphoma. Expanded access first, then recruiting, then newest first. Open any record for eligibility, locations and sponsor contact details.

Show all 42 Follicular Lymphoma records on this page

About this hub

Expanded access programs (sometimes called compassionate use, named-patient programs, or pre-approval access) allow patients with serious or life-threatening conditions such as Follicular Lymphoma to receive an investigational therapy outside of a controlled clinical trial when no comparable approved option is available. Eligibility, location, and the application process differ for each program — review the individual program pages below for sponsor contact information, inclusion criteria, and the request workflow. Right2Hope is a 501(c)(3) nonprofit and provides this directory free of charge for patients, caregivers, and treating physicians.

How access works: expanded access and Right to Try, explained in plain language.

Looking for a different condition? Browse the full Cancer Type hub directory or search the full expanded access program catalog.